Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | HCID 19963119 | HCID 19963119 | — |
| Product | HCID 19963176 | HCID 19963176 | — |
Reaction Steps
A mixture of 7-(2-bromoethoxy)-6-methoxy-4-(3'-methylanilino)quinazoline (0.25 g) and morpholine (4 ml) was stirred at ambient temperature for 4 hours. The mixture was evaporated and the residue was partitioned between methylene chloride and a dilute aqueous sodium bicarbonate solution. The organic phase was dried (MgSO4) and evaporated. The residue was triturated under diethyl ether to give 6-methoxy-4-(3'-methylanilino)-7-(2-morpholinoethoxy)quinazoline (0.198 g), m.p. 168°-170° C. NMR Spectrum: (CD3SOCD3 +CD3CO2D) 2.35 (s, 3H), 3.15 (t, 4H), 3.81 (t, 4H), 3.96 (s, 3H), 6.93 (d, 1H), 7.21 (s, 1H), 7.26 (t, 1H), 7.58 (s, 1H), 7.63 (d, 1H), 7.84 (s, 1H), 8.44 (s, 1H), 9.58 (s, 1H); Elemental Analysis: Found C, 64.3; H, 6.9; N, 13.8; C22H26N4O3. 0.9H2O requires C, 64.3; H, 6.8; N, 13.6%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05457105 |
|---|
| Source dataset | uspto-grants-1995_10 |
|---|
| ORD ID | ord-5c99a0aba0424fe98ec86faf033c942d |
|---|
| Source note | uspto-grants-1995_10 |
|---|